Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The tRNALys packaging complex in HIV-1.

Lawrence Kleiman1, Shan Cen

  • 1Lady Davis Institute for Medical Research, Jewish General Hospital, 3755 Cote St. Catherine Road, Montreal, Que., Canada H3T 1E2. lawrence.kleiman@mcgill.ca

The International Journal of Biochemistry & Cell Biology
|June 9, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanistic insights and therapeutic advances in antiviral strategies against African swine fever virus.

Acta pharmaceutica Sinica. B·2026
Same author

New nonacyclic duclauxin derivatives with potent anti-influenza activities from Antarctic fungus Penicillium sp. CPCC 401065.

Bioorganic chemistry·2026
Same author

Design, synthesis and evaluation of novel substituted 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives as potential anti-ZIKV agents.

Bioorganic chemistry·2026
Same author

Characterization of Storage-Induced mRNA Modifications in (<i>4S</i>)-KEL12 LNP: Adduct Formation Kinetics, mRNA Decay, and Translational Competence.

Molecular pharmaceutics·2026
Same author

Poly(A) variants supporting robust transmission stability in bacteria and high protein expression in animals for mRNA <i>in vitro</i> transcription.

Molecular therapy. Nucleic acids·2026
Same author

Mutation of the highly conserved amino acids in the N-terminal region of the EV-A71 VP1 protein impairs viral RNA release during virus entry.

Microbiology spectrum·2026

Human immunodeficiency virus type 1 (HIV-1) selectively packages specific lysine transfer RNAs (tRNALys) using a complex involving Gag, Gag-Pol, viral RNA, and lysyl-tRNA synthetase (LysRS). LysRS acts as a key signal for tRNALys incorporation into the virus.

Area of Science:

  • Virology
  • Molecular Biology
  • Biochemistry

Background:

  • Human immunodeficiency virus type 1 (HIV-1) requires specific host factors for replication, including transfer RNAs (tRNAs) that function as reverse transcription primers.
  • Lysine-specific tRNAs (tRNALys) are essential for HIV-1, with tRNALys3 serving as the primer for initiating reverse transcription.
  • The precise mechanisms governing the selective packaging of tRNALys into assembling HIV-1 virions remain incompletely understood.

Purpose of the Study:

  • To review and present evidence supporting a model for the formation of a tRNALys packaging complex during HIV-1 assembly.
  • To elucidate the roles of viral proteins (Gag, Gag-Pol) and host factors (tRNALys, LysRS) in this packaging process.
  • To identify the specific interactions and signals that mediate the selective incorporation of tRNALys into HIV-1.

Related Experiment Videos

Main Methods:

  • Review of existing experimental evidence and proposed models.
  • Analysis of protein-protein and protein-RNA interactions within the HIV-1 assembly pathway.
  • Examination of the role of reverse transcriptase sequences in Gag-Pol and the function of LysRS.

Main Results:

  • A model is proposed where a tRNALys packaging complex forms through the interaction of Gag/Gag-Pol/viral RNA complexes with tRNALys/LysRS complexes.
  • Gag interacts with LysRS, while Gag-Pol interacts with tRNALys, facilitating complex formation.
  • Reverse transcriptase sequences in Gag-Pol bind tRNALys, essential for its viral packaging. LysRS, the enzyme for tRNALys aminoacylation, is also incorporated and acts as a specific signal for tRNALys incorporation.
  • LysRS incorporation into virions occurs via Gag interaction and is independent of tRNALys packaging, while tRNALys incorporation depends on LysRS interaction but not aminoacylation.

Conclusions:

  • The formation of a tRNALys packaging complex is a multi-component process involving specific interactions between viral and host factors.
  • Lysyl-tRNA synthetase (LysRS) plays a critical role as a targeting signal for the selective incorporation of tRNALys into HIV-1 virions.
  • While tRNALys interaction with LysRS is crucial for packaging, its aminoacylation status is not a prerequisite for incorporation into HIV-1.